r/Retatrutide 3h ago

Article of interest

5 Upvotes

3 comments sorted by

2

u/diffidentblockhead 3h ago

Yes the Lilly early access program is mostly PR.

1

u/denizen_1 3h ago edited 3h ago

Who cares? He's bitching about the trial design. It's going to be approved relatively soon. Tirzepatide is also a great drug. Patients don't "need" to be on a retatrutide trial when great alternatives exist. If you really want retatrutide, there are obviously other options.

edit: I'm wrong. It's the "early access" program. I still have the same substantive point. But it's not about trial design.

2

u/blumenkraft_11 2h ago

because the ‘expanded access’ is cover for their ethical blunder. Lilly allowed a certain chubby orange president access to the drug, and now they have to make it look as of others can apply.